Domain Summary

folliclethought.com

featured articles the best news in the industry article feed for a list of all recent articles click here as seen in the new yorker instyle trends in biotechnology next previous connect with us let’s talk, socially

folliclethought.com Quick Summary

Global rank: #168197
Daily visitors: 5.46K
Monthly Visits: 163,904
Pageviews per user: 1.72
Registrar Abuse Contact Email:
Registrant Phone:
Rating
TLD: com
IP Address: 50.87.24.127
Organization: Unified Layer
Category: Health >
Health Conditions and Concerns
folliclethought.com Icon
folliclethought.com
Last Status:
Online
Last Updated: 8 day ago
loading

About Website

Click here to check amazing folliclethought content for Japan. Otherwise, check out these important facts you probably never knew about folliclethought.com

featured articles the best news in the industry article feed for a list of all recent articles click here as seen in the new yorker instyle trends in biotechnology next previous connect with us let’s talk, socially

Visit folliclethought.comRight Arrow
Trust Score DNS Competitors Traffic SSL HTTP Headers WHOIS Reviews SEO

folliclethought.com Trust Score

folliclethought.com is probably legit as the trust score is reasonable. Our algorithm rated folliclethought.com a 88. Although our rating of folliclethought.com is medium to low risk, we encourage you to always vote as the evaluation of the site is done automatically.

The trust rating is high. Might be safe.
Trustscore
88 / 100

What is your feeling about folliclethought.com?

rating 10
rating 20
rating 31
rating 40
rating 50
3.0 / 5 Based on 1 Reviews
View/Add Comments

Which Sites are Alternatives & Competitors to folliclethought.com?

Explore the top alternatives and rivals of folliclethought.com in November 2024, and assess their data relating to website traffic, SEO, Web Server Information, and Whois. Refer to the list below for the best competitors of folliclethought.com, and simply click on each one to delve into their specific details.

Mentioned on Their Website:

  • folliclethought.com
    Kintor Pharmaceutical KX-826 Phase 2 Results With Poster

    https://folliclethought.com/kintor-pharmaceutical-kx-826-phase-2-results-with-poster/

    KX-826 Phase 2 Results Presentation. Several months ago in May, the 28th Annual Meeting of the Chinese Society of Dermatology was postponed from June to the …

  • folliclethought.com
    About - Follicle Thought

    https://folliclethought.com/about/

    Mission Statement. To bring forth the most relevant information about leading-edge hair growth technology and discovery. To advocate global awareness …

  • reddit.com
    RiverTown Therapeutics: 6 Months Results : r/tressless - Reddit

    https://www.reddit.com/r/tressless/comments/bopm9t/rivertown_therapeutics_6_months_results/

    FollicleThought_com • • Edited Additional comment actions It's really surprising to me how much conversation gets tossed around when a professor in Korea discovers some university research but when there is an actual product that is regenerating hair on even old guys (harder to do) the internet folk just kind of twiddle their thumbs.

  • reddit.com
    New company bringing Minoxidil + Finasteride + Bimatoprost …

    https://www.reddit.com/r/tressless/comments/g2dvaj/new_company_bringing_minoxidil_finasteride/

    49 votes, 25 comments. 163K subscribers in the tressless community. Tressless (*tress·less*, without hair) is the most popular community for males…

  • reddit.com
    HairClone received grant money to begin their work after ... - Reddit

    https://www.reddit.com/r/tressless/comments/eldzmh/hairclone_received_grant_money_to_begin_their/

    FollicleThought_com • Additional comment actions It's different, it's multiplied dermal papilla cells to thicken and rejuvenate miniaturizing hair but not grow brand new follicles.

  • reddit.com
    Most promising hair cloning research to date seeks industry ... - Reddit

    https://www.reddit.com/r/tressless/comments/hbiui5/most_promising_hair_cloning_research_to_date/

    y FollicleThought_com. View community ranking In the Top 1% of largest communities on Reddit. Most promising hair cloning research to date seeks industry partners for commercialization . folliclethought This thread is archived New comments cannot be posted and votes cannot be cast ...

  • twitter.com
    Follicle Thought.com (Hair Growth Research) on Twitter: "Hair …

    https://twitter.com/FollicleThought/status/1646856295293526016

    Hair Growth Industry Happenings Spring 2023 article published yesterday including companies not discussed before and some familiar names like JW Pharmaceutical who ...

  • reddit.com
    Cosmo Pharma Lists Breezula Phase 3 Trial on ClinicalTrials.gov

    https://www.reddit.com/r/tressless/comments/14i46co/cosmo_pharma_lists_breezula_phase_3_trial_on/

    A trial which was once highly anticipated, then questioned if it would ever happen, will now be back on everyone’s radar. On June 18, 2023, a phase 3 trial listing of a 5% clascoterone solution (aka Breezula) treating male AGA was posted on the official clinical trials website. The SCALP1 study will comprise 726 participants and will involve ...

  • folliclethought.com
    Mallia Therapeutics Secures Funding For Hair Growth Drug CD83

    https://folliclethought.com/mallia-therapeutics-secures-funding-for-hair-growth-drug-cd83/

    The German biotech startup Mallia Therapeutics (formerly MalliaBiotech) has secured seed funding to further its hair loss drug soluble CD83. CD83 Hair Growth Through Immune Modulation On July 11, 2023, Mallia Therapeutics issued a press release announcing a successful seed financing round and the presentation of data at a …

  • folliclethought.com
    Revivv.co Hair Growth Serum Product Reviews With Photos

    https://folliclethought.com/revivv-co-hair-growth-serum-product-reviews-with-photos/

    I’m going to take this opportunity to set a tone and improve future user reviews. When providing feedback on your use of Revivv, please share how long you’ve been using the product and keep your review based on your experience with the product, applying it, and how it has affected your hair/scalp.

  • folliclethought.com
    Translated by https://www.folliclethought.com/

    https://www.folliclethought.com/wp-content/uploads/2018/03/Translated-copy-of-Yokohama-Tricho-Seeds-Co-Press-Release.pdf

    Attachment Material Ministry of Education, Culture, Sports, Science and Technology Regional I Formation Program Overview

  • folliclethought.com
    WAY-316606 Product Release Update 2020 - Follicle Thought

    https://folliclethought.com/way-316606-product-release-update-2020/

    Around this time last year, Dr. Marzani shared with Follicle Thought that Giuliani was investigating several analogs of WAY-316606, one of which could be developed as an over-the-counter aka cosmetic hair growth treatment. An analog is a molecule which has a similar structure to another molecule and may have a similar …

  • folliclethought.com
    Updates Archive - Follicle Thought

    https://folliclethought.com/updates/

    Updates Archive - Follicle Thought. Cures For Hair Loss 2023 - News Feed. A very good idea is to bookmark this article page in your browser or mobile browser for …

  • folliclethought.com
    Verteporfin Could Create Scarless Hair Transplant Surgery

    https://folliclethought.com/verteporfin-could-create-scarless-hair-transplant-surgery/

    New research from Stanford University may have uncovered a new useful application for hair restoration surgery. Stanford Stops The Engrailed-1 Last month in April, a research team from Stanford University headed by Dr. Michael Longaker, published a study on scarless wound healing which captured mainstream attention. The peer …

  • reddit.com
    All Drugs in Clinical Trials in 2023 : r/tressless - Reddit

    https://www.reddit.com/r/tressless/comments/107e70x/all_drugs_in_clinical_trials_in_2023/

    Around 12 companies will have drugs/therapies in clinical trials during 2023, maybe more depending on any newcomers. Kintor - has KX-826, an AR antagonist, in phase 3 in China and phase 2 in US. Hope Medicine - in a phase 1 in Australia for PRL antibody drug. Technoderma Medicines - Website indicates that a phase 2 will be starting in US by ...

  • reddit.com
    New company created by Dr. Kang-Yell Choi to commercialize …

    https://www.reddit.com/r/tressless/comments/iehdvw/new_company_created_by_dr_kangyell_choi_to/

    I remember hearing about Choi like 2.5 years ago, and we were all saying it was the holy grail, the cure was here. Then nothing. I know some people had a lab create the compound and bought some, but I don't remember hearing anything about their results.

  • folliclethought.com
    JAK Inhibitors Show Great Potential as a Hair Loss Treatment

    https://folliclethought.com/jak-inhibitors-show-great-potential-as-a-hair-loss-treatment/

    Angela Christiano is up to it again, and the online hair world is very thankful. It was just a little over a year ago when the internet was ablaze with the news that Dr. Angela Christiano and her colleagues were studying the pharmaceutical drug ruxolitinib in cases of alopecia areata. Like tofacitinib, ruxolitinib is a type of drug known as a JAK …

  • folliclethought.com
    WAY-316606 Clinical Trial Update 2019 - Follicle Thought

    https://folliclethought.com/way-316606-clinical-trial-update-2019/

    WAY-316606 Clinical Trial Update 2019. One of the most popular hair-growth research discoveries in recent years is finally making its way into clinical trials. If successful, a product could become available sooner than expected. In May 2018, an article published in the PLOS journal by Hawkshaw et al., showed that SFRP1 inhibition was a …

  • folliclethought.com
    Fukuda Lab & Yokohama University: Hair Cloning Update

    https://folliclethought.com/fukuda-lab-yokohama-university-cloning-update/

    University based research is always welcomed news, however at Follicle Thought we are focused on solutions. I thought it would be worthwhile to understand …

  • reddit.com
    Minoxidil Enhancing Shampoo via Sulfotransferase Enzymes

    https://www.reddit.com/r/tressless/comments/drjy4y/minoxidil_enhancing_shampoo_via_sulfotransferase/

    Your reminder is in 6 month s on 2020-05-04 18:42:21Z : /r/tressless: Minoxidil_enhancing_shampoo_via_sulfotransferase#1. This thread is popping 🍿. Here is reminder sequel if needed . 8 OTHERS CLICKED THIS LINK to also be reminded. Thread has 22 reminders and maxed out 4 confirmation comments. Additional confirmations are …

  • folliclethought.com
    Follicum Doses First Patients In Topical Phase 2 Trial

    https://folliclethought.com/follicum-doses-first-patients-in-topical-phase-2-trial/

    Follicum’s most important trial to date has officially begun in Germany. On March 9, 2020, the Swedish biotech company Follicum announced that its phase 2 dose-ranging study of FOL-005 is now officially underway. The trial will include 200 men with male pattern hair loss who will apply either the hair growth drug or placebo once daily for …

  • folliclethought.com
    Kintor Announces New Advanced Androgen Receptor Drug …

    https://folliclethought.com/kintor-announces-new-advanced-androgen-receptor-drug-gt20029/

    The trial of GT20029, which is an androgen receptor degrader drug, is a multi-center, randomized, double-blind, placebo-controlled study designed to evaluate …

  • folliclethought.com
    RiverTown Therapeutics Inc. Results: Exclusive - Follicle Thought

    https://folliclethought.com/rivertown-therapeutics-results-exclusive/

    This week, David Weinstein, MD, PhD of RiverTown Therapeutics Inc. reached out to me to share some amazing photo results of his new compound RT1640. …

  • folliclethought.com
    Hope Medicine Gets Approval For Phase 2 Hair Loss Trial Of …

    https://folliclethought.com/hope-medicine-gets-approval-for-phase-2-trial-of-hmi-115/

    On January 25, 2022, Hope Medicine issued a press release announcing that the US FDA has approved the investigational new drug (IND) application for their antibody therapy …

  • folliclethought.com
    Samumed Phase 3 Trial Is Underway - Follicle Thought

    https://folliclethought.com/samumed-phase-3-trial-is-underway/

    The news of the day is Samumed’s phase 3 trial for androgenic alopecia is underway. It will take some time before the trial comes to completion, but having the trial in progress is a major accomplishment. The update released by the company seen below states the trial is taking place outside the US. It can be noted that Samumed previously ...

  • cell.com
    The booming business of hair loss: Trends in Biotechnology - Cell …

    https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(22)00348-1

    AGA is the most common nonscarring pathological hair loss disorder. It affects 50 million men and 30 million women in the USA. This has led to an unprecedented demand for both preventive and therapeutic interventions. The global alopecia market size was valued at $7.6 billion in 2020 and is expected to reach $13 billion by 2028 i.

  • reddit.com
    Allergan Sinks $25 Million Into New Baldness Cure : r/tressless - Reddit

    https://www.reddit.com/r/tressless/comments/dwt5ql/allergan_sinks_25_million_into_new_baldness_cure/

    Tressless (*tress·less*, without hair) is the most popular community for males and females coping with hair loss. Feel free to discuss remedies, research, technologies, hair transplants, hair systems, living with hair loss, cosmetic concealments, whether to "take the plunge" and shave your head, and how your treatment progress or shaved head or …

  • reddit.com
    Stemson Therapeutics and hair cloning pipeline : r/tressless - Reddit

    https://www.reddit.com/r/tressless/comments/cu0xd9/stemson_therapeutics_and_hair_cloning_pipeline/

    Im just happy to see more companys that goes the same path. The first company that will realse their product will lunch the triger for the rest !

  • folliclethought.com
    HMI-115 Begins Phase 2 Trial In China - Follicle Thought

    https://folliclethought.com/hmi-115-begins-phase-2-trial-in-china/

    The phase 2 trial began September 2023 and is expected to complete by December 2024. The trial is randomized, multicenter, double-blind, and placebo-controlled. Primary outcome is the mean change in target area hair count (TAHC) of non-vellus hairs from baseline. Norwood scales 3 vertex, 4, and 5 will be accepted to participate.

  • folliclethought.com
    Histogen Begins Late Stage Trial In Mexico - Follicle Thought

    https://folliclethought.com/histogen-begins-late-stage-trial-in-mexico/

    I’d recommend sending them an email and request an interview with FollicleThought.com! Truthfully, companies listen to this feedback most of the time. Search Search. Subscribe to Blog via Email. Enter your email address to subscribe to this blog and receive notifications of new posts by email.

  • folliclethought.com
    CarthroniX: New Company - Follicle Thought

    https://folliclethought.com/carthronix-new-company/

    CarthroniX is based in Lancaster, CA, a city in northern Los Angeles County. The company was founded by Dr. Denis Evseenko MD, PhD, and Dr. Ben Van Handel and has roots in the prestigious universities of USC and UCLA. There are currently seven indications listed in the CarthroniX pipeline, among them, hair loss and wound healing.

  • folliclethought.com
    Stemson Therapeutics Raises $15M To Bolster Hair Regeneration Efforts

    https://folliclethought.com/stemson-therapeutics-raises-15m-to-bolster-hair-regeneration-efforts/

    The company founded on Alexey Terskikh’s hair multiplication research at the Sanford Burnham Prebys Institute has not had a problem raising capital since its inception a few years ago. In a press release issued today, July, 15, 2021, Stemson Therapeutics announced the closing of a $15 million Series A financing round. DCVC-Bio and Genoa …

See More

DNS Lookup

DNS entries, such as A, NS, MX, and TXT records, are crucial for the functioning of the Internet. The A record maps a domain name to an IPv4 address, while the NS record specifies authoritative name servers for a domain. The MX record identifies the mail server responsible for receiving email messages for a domain. Additionally, the TXT record allows for the association of any text information with a domain name. These records play a vital role in ensuring proper communication and connectivity across the internet.

N/A.

folliclethought.com Traffic Analysis

According to global rankings, folliclethought.com holds the position of #168197. It attracts an approximate daily audience of 5.46K visitors, leading to a total of 5576 pageviews. On a monthly basis, the website garners around 163.9K visitors.

Daily Visitors5.46K
Monthly Visits163.9K
Pages per Visit1.72
Visit Duration0:01:17
Bounce Rate66.95%
Want complete report?Full SEMrush Report >>
Daily Unique Visitors:
5463
Monthly Visits:
163904
Pages per Visit:
1.72
Daily Pageviews:
5576
Avg. visit duration:
0:01:17
Bounce rate:
66.95%
Monthly Visits (SEMrush):
166360

Traffic Sources

SourcesTraffic Share
Social:
0.93%
Paid Referrals:
1.88%
Mail:
0.00%
Search:
19.34%
Direct:
77.85%

Visitors by Country

CountryTraffic Share
United States:
20.43%
Canada:
10.75%
Croatia:
8.94%
Bulgaria:
8.14%
Poland:
3.94%

SSL Checker - SSL Certificate Verify

An SSL certificate is a digital certificate that ensures a secure encrypted connection between a web server and a user's browser. It provides authentication and encryption to keep data private and protected during transmission. folliclethought.com supports HTTPS, demonstrating their commitment to providing a secure browsing experience for users.

HTTP Headers

HTTP headers are additional segments of data exchanged between a client (e.g. a web browser) and a server during an HTTP request or response. They serve to provide instructions, metadata, or control parameters for the interaction between the client and server.

Status
HTTP/1.1 302 Found
Date
Fri, 07 Jun 2024 10:37:10 GMT
Server
Apache
Upgrade
h2,h2c
Connection
Upgrade
X-Endurance-Cache-Level
0
X-nginx-cache
WordPress
Content-Type
text/html; charset=UTF-8

Where is folliclethought.com hosted?

folliclethought.com is likely hosted in various data centers located across different regions worldwide. The current data center mentioned is just one of many where the website may be hosted.

Whois Information

WHOIS protocol used to get domain/IP info. Common for reg details, ownership of a domain/IP. Check folliclethought.com for reg/admin contact info, owner, org, email, phone, creation, and expiration dates.

Domain Updated Date:
Domain Created Date:
Domain Expiry Date:
Domain Name:
Registrar WHOIS Server:
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Registrar:
Domain Owner:

N/A.

SEO Analysis

SEO analysis involves examining the performance of a website, including titles, descriptions, keywords, and website speed. It also includes identifying popular keywords and researching competitor websites to understand their strategies. The analysis aims to optimize the website's visibility and improve its ranking on search engines.

Website Speed Test (Desktop):
0.08 seconds

Website speed is a measurement of how fast the content on your page loads. Website speed is one of many factors involved in the discipline of search engine optimization (SEO), but it is not the only one. In a recent study, the average load time for a web page was 3.21s.

Top Organic Search Terms:
Term Search Volume Traffic Traffic (%)
folliclethought 90 0 0%

CO-Hosted

CoHosted refers to a situation where multiple domain names (websites) are using the same IP address to point to their respective web servers. They could be owned by different individuals or organizations and may serve entirely different purposes.

folliclethought.com

People reviews about folliclethought.com

Very positive reviews

rating 5

Total reviews: 2
Average score: 5 stars

The total score is based on reviews found on the following sites
Scamadviser: 5/5 stars, 2 reviews

Add your review

rating 1 rating 2 rating 3 rating 4 rating 5

Very positive reviews

rating 5

Total reviews: 2
Average score: 5 stars

The total score is based on reviews found on the following sites
Scamadviser: 5/5 stars, 2 reviews


Back Top
Feedback